Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Novartis scraps cholesterol drug trial in blow to UK life sciences ambitions

Swiss firm’s withdrawal from Leqvio trial with NHS dents government plans to attract post-Brexit research and investment

The Guardian - UK

LOCALIZE IT: States weigh stricter fentanyl penalties

EDITORS/NEWS DIRECTORS:

The Independent UK

The Best Medical Stock That Money Can Buy

The medical industry, which thrived during the pandemic years, is envisioned to remain buoyed despite the economic headwinds, thanks to the inelastic demand the sector faces. Against this backdrop, we think the strong fundamentals of Johnson and Johnson (JNJ) make it a wise portfolio addition. Read on….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

US issues warning about Mexican pharmacies selling tainted, counterfeit pills

The U.S. State Department issued a warning Friday for Americans to “exercise caution” when buying medications from drug stores in Mexico, posting the health alert a week after a letter from two lawmakers and an investigation by the Los Angeles Times.

Los Angeles Times

Newsom announces $50 million contract to make California’s own brand of insulin

LOS ANGELES — California Gov. Gavin Newsom announced a new $50-million contract with the nonprofit generic drugmaker Civica to produce insulin under the state’s own label during a news conference Saturday in Downey.

Los Angeles Times

Four people forced to have their eyeballs removed after using contaminated eye drops

The Centres for Disease Control and Prevention has identified a rare strain of Pseudomonas aeruginosa in 68 patients across 16 states in the US due to contaminated eyedrops

Daily Mirror

Amid U.S. pressure on fentanyl, Mexico raises drug lab raids data

Mexico's army has dramatically revised upward the number of drug lab raids it says it conducted under President Andres Manuel Lopez Obrador, according to government data and leaked military documents reviewed by Reuters.

Reuters

Read news from The Economist, FT, and more,
with one subscription

Firm behind Wegovy slimming jab suspended from UK trade association

Novo Nordisk found to be in breach of ABPI code of practice over sponsored weight-loss courses that promoted its medicines

The Guardian - UK

Judge weighs FDA approval of abortion drug

WASHINGTON — A federal district judge heard oral arguments Wednesday in a controversial case that could decide the fate of the Food and Drug Administration’s approval of the abortion drug mifepristone — a decision that would have broad ramifications nationwide.

Tribune News Service

Federal government to penalize AbbVie over the price of its blockbuster drug Humira

North Chicago-based drugmaker AbbVie must pay back Medicare for raising the price of its blockbuster drug Humira too quickly, the federal government said Wednesday.

Chicago Tribune

Jeremy Hunt aims to spur business investment with ‘full expensing’ tax break

Measure over next three years will allow firms to write off costs of IT equipment and machinery against tax on profits

The Guardian - UK

Governments are increasingly reliant on consulting firms. Critics says it's often to their detriment

Critics say governments are outsourcing their own knowledge and activities to consulting firms, yet these firms aren't held to the same standards as the public sector.

ABC News

‘Near-automatic sign off’ – Hunt pledges £10m to speed up access to new drugs

The Chancellor said that £10 million would be awarded to help streamline approvals for new medical products.

The Independent UK

The Smartest Stock to Buy for Under $50 Now

Pharma giant Pfizer (PFE) had a successful fiscal year 2022 with record-breaking revenue and earnings. Moreover, its recent acquisition should boost its portfolio and revenue. Given the market volatility, this fundamentally strong stock might be an ideal buy for under $50. Keep reading.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

1 Stock to Buy This Week and Hold for the Next 20 Years

Although the stock market remains highly volatile, investing for the long term can never be timed perfectly. I believe buying fundamentally strong biopharmaceutical major Bristol-Myers Squibb (BMY) now for the long term could be wise, given the solid prospects of its new drug launches. Read more….

The Independent UK

Novo Nordisk to slash insulin price by up to 75% in push for affordable diabetes treatments

The brand is the latest to plan dramatic price cuts for the diabetes drug

Radio France Internationale

Rwanda welcomes Africa's first mobile vaccine-production units

Six mobile vaccine-production units developed by German pharmaceutical company BioNTech have arrived in Rwanda. This is the first such shipment to Africa as the continent seeks to boost local production of mRNA vaccines.

Tribune News Service

The VA will pay for some to get new Alzheimer’s drug

The U.S. Veterans Health Administration will pay for some beneficiaries to get a new Alzheimer’s disease drug from Eisai Co. and Biogen Inc., positive news for a treatment that Eisai expects to bring in billions of dollar in sales in the next few years.

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Pfizer to pay $43 billion for Seagen, set post-COVID course

Pfizer Inc. is purchasing cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, using the biggest deal of the year to set its course out of the pandemic and back into mainstream pharma.

StockNews.com

This Big Pharma Stock Is a Clear Buy in 2023

With interest rates expected to be higher than originally anticipated and fears of a looming recession weighing heavily on investors’ decisions, the stock market is expected to remain under pressure this year. Amid this backdrop, it could be wise for investors to invest in Johnson & Johnson (JNJ) due to…

StockNews.com

2 Top Biotech Stocks to Buy in March

The biotech industry is expected to witness solid growth amid impressive advancements and government initiatives. Moreover, the biotech sector tends to be more defensive than others during market downturns. So, fundamentally sound biotech stocks Amgen (AMGN) and Biogen (BIIB) might be ideal buys now. Keep reading.

Tribune News Service

Pfizer to buy cancer drugmaker Seagen in $43 billion deal

Pfizer Inc. agreed to purchase cancer-drug maker Seagen Inc. for an enterprise value of $43 billion, gaining the company’s antibody drugs that fight tumors.

Ballotpedia

Democratic attorneys general sue Biden administration over FDA abortion pill regulation

A group of 12 Democratic state attorneys general filed a lawsuit in the United States District Court for the Eastern District of Washington against the Food and Drug Administration (FDA) on Feb. 23, 2023, arguing that the agency’s regulations on the abortion-inducing drug mifepristone violate state sovereignty by limiting the…

The Independent UK

Pfizer will spend $43 billion to acquire Seagen

Pfizer will spend about $43 billion to buy Seagen and broaden its reach into cancer treatments, the pharmaceutical giant said Monday

The Independent UK

FDA approves world’s first fast-acting nasal spray to treat migraines

Drug marks ‘significant breakthrough’ for people with migraine who need freedom from pain

1 … 54 55 56 57

People

Dipanjan BanchurSince

722 stories

Lopez Obrador

323 stories

Andres Manuel Lopez Obrador

317 stories

Matthew Kacsmaryk

224 stories

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.